Works matching DE "BELIMUMAB"

Results: 319

Az antifoszfolipid szindróma aktualitásai.

Published in:

Lege Artis Medicine (LAM), 2025, v. 35, n. 4, p. 187, doi. 10.33616/lam.35.0188

By:

JÚLIA, TAKÁCS;
JUDIT, VÉGH;
VIRÁG, KISS EMESE

Publication type:

Article

Evaluation of the efficacy and safety of belimumab and telitacicept in patients with systemic lupus erythematosus: results from a retrospective, observational study.

Published in:

Clinical & Experimental Medicine, 2025, v. 25, n. 1, p. 1, doi. 10.1007/s10238-025-01640-z

By:

Feng, Tianxiao;
Zhang, Manyu;
Wang, Jieying;
Li, Yang;
Cui, Yang

Publication type:

Article

Efficacy of belimumab monotherapy in high infectious risk patient affected by lupus nephritis.

Published in:

Rheumatology Advances in Practice, 2021, v. 5, n. 1, p. 1, doi. 10.1093/rap/rkab023

By:

D'Alessandro, Roberto;
Gonzalez, Estrella Garcia;
Frediani, Bruno

Publication type:

Article

META-ANALYSIS ON THE EFFICACY AND SAFETY OF BELIMUMAB FOR LUPUS NEPHRITIS BY USING THE PUBMED DATABASE.

Published in:

Farmacia, 2023, v. 71, n. 5, p. 888, doi. 10.31925/farmacia.2023.5.2

By:

QIYUAN CHEN;
FANGZHOU GU;
LI LIU

Publication type:

Article

Belimumab in early systemic lupus erythematosus: A propensity score matching analysis.

Published in:

Immunity, Inflammation & Disease, 2024, v. 12, n. 8, p. 1, doi. 10.1002/iid3.1362

By:

Lu, Chaofan;
He, Nan;
Dou, Lei;
Yu, Hongxia;
Li, Mengtao;
Leng, Xiaomei;
Zeng, Xiaofeng

Publication type:

Article

Efficacy and safety of belimumab therapy for patients with lupus nephritis: A meta‐analysis and a propensity score‐matched case–control study.

Published in:

Immunity, Inflammation & Disease, 2023, v. 11, n. 7, p. 1, doi. 10.1002/iid3.954

By:

Zhang, Kai;
Qi, Tiening;
Guo, Donghua;
Liu, Youxia

Publication type:

Article

Short‐term clinical observations of belimumab in the treatment of recently diagnosed systemic lupus erythematosus.

Published in:

Immunity, Inflammation & Disease, 2022, v. 10, n. 11, p. 1, doi. 10.1002/iid3.716

By:

Wu, Chunye;
Gong, Baoqi

Publication type:

Article

High expression of B lymphocyte stimulator in lesional keratinocytes of patients with cutaneous lupus erythematosus.

Published in:

Experimental Dermatology, 2018, v. 27, n. 1, p. 95, doi. 10.1111/exd.13419

By:

Wenzel, Joerg;
Landmann, Aysche;
Vorwerk, Gero;
Kuhn, Annegret

Publication type:

Article

Belimumab‐induced papular elastorrhexis: A case report.

Published in:

Australasian Journal of Dermatology, 2023, v. 64, n. 4, p. e396, doi. 10.1111/ajd.14174

By:

Gil‐Lianes, J.;
Luque‐Luna, M.;
Albanell‐Fernández, C.;
Castillo, P.;
Espinosa, G.;
Mascaró, J. M.

Publication type:

Article

Treatment‐resistant systemic lupus erythematosus‐associated hypocomplementic urticarial vasculitis successfully treated with belimumab.

Published in:

Australasian Journal of Dermatology, 2023, v. 64, n. 2, p. 301, doi. 10.1111/ajd.13995

By:

Peñuelas Leal, Rodrigo;
Labrandero Hoyos, Carolina;
Partarrieu Mejías, Felipe;
Grau Echevarría, Andrés;
Lorca Spröhnle, Javier;
Casanova Esquembre, Andrés;
Esteve Martínez, Altea;
Zaragoza Ninet, Violeta

Publication type:

Article

Efficacy and safety of belimumab combined with the standard regimen in treating children with lupus nephritis.

Published in:

European Journal of Pediatrics, 2024, v. 183, n. 9, p. 3987, doi. 10.1007/s00431-024-05662-9

By:

Li, Huarong;
Chen, Chaoying;
Yang, Hongxian;
Tu, Juan

Publication type:

Article

Alopecia areata: Update on management.

Published in:

Indian Journal of Paediatric Dermatology, 2017, v. 18, n. 4, p. 261, doi. 10.4103/ijpd.IJPD_80_17

By:

Kranseler, Julie S.;
Sidbury, Robert

Publication type:

Article

Neutralization of B-Cell Activating Factor (BAFF) by Belimumab Reinforces Small Molecule Inhibitor Treatment in Chronic Lymphocytic Leukemia.

Published in:

Cancers, 2020, v. 12, n. 10, p. 2725, doi. 10.3390/cancers12102725

By:

Tandler, Claudia;
Schmidt, Moritz;
Heitmann, Jonas S.;
Hierold, Julia;
Schmidt, Jonas;
Schneider, Pascal;
Dörfel, Daniela;
Walz, Juliane;
Salih, Helmut R.

Publication type:

Article

贝利尤单抗用于儿童系统性红斑狼疮的研究进展.

Published in:

Chinese Journal of Contemporary Pediatrics, 2021, v. 23, n. 10, p. 1069, doi. 10.7499/j.issn.1008-8830.2107153

By:

邓伟萍;
综述胡长平;
罗平;
审校

Publication type:

Article

Belimumab in the treatment of Portuguese systemic lupus erythematosus patients: a real-life multicenter study.

Published in:

Acta Reumatológica Portuguesa, 2020, v. 45, n. 3, p. 170

By:

B. M., Fernandes;
S., Barreira;
J. E., Fonseca;
M., Cunha;
M. J., Santos;
N., Gonçalves;
A. L., Fernandes;
J., Rodrigues;
T., Fontes;
L., Costa;
M, Bernardes

Publication type:

Article

Systemic lupus erythematosus... [including commentary by Kay Blackhall].

Published in:

Nursing Standard, 2016, v. 30, n. 43, p. 17, doi. 10.7748/ns.30.43.17.s21

By:

Pearce, Lynne

Publication type:

Article

A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol.

Published in:

Trials, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s13063-023-07218-y

By:

McClure, Mark E.;
Gopaluni, Seerapani;
Wason, James;
Henderson, Robert B.;
Van Maurik, Andre;
Savage, Caroline C.O.;
Pusey, Charles D.;
Salama, Alan D.;
Lyons, Paul A.;
Lee, Jacinta;
Mynard, Kim;
Jayne, David R.;
Jones, Rachel B.

Publication type:

Article

Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial.

Published in:

2022

By:

van Schaik, Mieke;
Arends, Eline J.;
Soonawala, Darius;
van Ommen, Ellen;
de Leeuw, Karina;
Limper, Maarten;
van Paassen, Pieter;
Huizinga, Tom W. J.;
Toes, René E. M.;
van Kooten, Cees;
Rotmans, Joris I.;
Rabelink, Ton J.;
Teng, Y. K. Onno

Publication type:

journal article

Distinct binding mode of BAFF antagonist antibodies belimumab and tabalumab, analyzed by computer simulation.

Published in:

Journal of Molecular Modeling, 2022, v. 28, n. 10, p. 1, doi. 10.1007/s00894-022-05142-7

By:

Jiang, Yaxin;
Sun, Jian;
Wei, Jing

Publication type:

Article

Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients.

Published in:

Medicina (1010660X), 2023, v. 59, n. 8, p. 1362, doi. 10.3390/medicina59081362

By:

Capdevila, O.;
Mitjavila, F.;
Espinosa, G.;
Caminal-Montero, L.;
Marín-Ballvè, A.;
González León, R.;
Castro, A.;
Canora, J.;
Pinilla, B.;
Fonseca, E.;
Ruiz-Irastorza, G.

Publication type:

Article

Targetoid lesions in a patient with systemic lupus erythematosus.

Published in:

Dermatology Online Journal, 2021, v. 27, n. 2, p. 1, doi. 10.5070/d3272052390

By:

Imtiaz, Rasheen;
Hornback, Cheyenne;
Eslam, Mohamed;
Crowson, A. Neil;
Levin, Jarad

Publication type:

Article

Role of belimumab in recurrent spontaneous abortions amongst patients with lymphocyte dysfunction: a retrospective case-control study.

Published in:

BMC Pregnancy & Childbirth, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12884-025-07600-5

By:

Liu, Lijuan;
Ma, Xiao;
Liu, Juan;
Fu, Jinhua;
Li, Ning;
Yuan, Guiling;
Zhao, Long

Publication type:

Article

Die 2023 EULAR-Empfehlungen zur Behandlung des systemischen Lupus erythematodes – Implikationen für die Versorgung in Deutschland.

Published in:

Zeitschrift für Rheumatologie, 2024, v. 83, n. 6, p. 431, doi. 10.1007/s00393-024-01544-5

By:

Mucke, Johanna;
Aringer, Martin

Publication type:

Article

Safety and efficacy of telitacicept in refractory systemic lupus erythematosus patients who failed treatment with belimumab: A case series.

Published in:

Zeitschrift für Rheumatologie, 2024, v. 83, n. 5, p. 387, doi. 10.1007/s00393-023-01461-z

By:

Fan, Qiuyu;
Yang, Huiqin;
Liu, Ya

Publication type:

Article

Effect of belimumab on kidney-related outcomes in patients with lupus nephritis: post hoc subgroup analyses of the phase 3 BLISS-LN trial.

Published in:

Nephrology Dialysis Transplantation, 2023, v. 38, n. 12, p. 2733, doi. 10.1093/ndt/gfad167

By:

Anders, Hans-Joachim;
Furie, Richard;
Malvar, Ana;
Zhao, Ming-Hui;
Hiromura, Keiju;
Weinmann-Menke, Julia;
Green, Yulia;
Jones-Leone, Angela;
Negrini, Daniela;
Levy, Roger A;
Lightstone, Liz;
Tanaka, Yoshiya;
Rovin, Brad H

Publication type:

Article

Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results.

Published in:

Nephrology Dialysis Transplantation, 2021, v. 36, n. 8, p. 1474, doi. 10.1093/ndt/gfaa117

By:

Kraaij, Tineke;
Arends, Eline J;
Dam, Laura S van;
Kamerling, Sylvia W A;
Daele, Paul L A van;
Bredewold, Obbo W;
Ray, Argho;
Bakker, Jaap A;
Scherer, Hans U;
Huizinga, Tom J W;
Rabelink, Ton J;
Kooten, Cees van;
Teng, Y K Onno

Publication type:

Article

Efficacy and Safety of Belimumab in Lupus Nephritis Patients: A Real-World Observational Study in China.

Published in:

Kidney Diseases, 2023, v. 9, n. 3, p. 1, doi. 10.1159/000529675

By:

Tan, Meng;
Xu, Jing;
Tan, Ying;
Qu, Zhen;
Yu, Feng;
Zhao, Minghui

Publication type:

Article

Effectiveness and Safety of Belimumab in Chinese Lupus Patients: A Multicenter, Real-World Observational Study.

Published in:

Biomedicines, 2023, v. 11, n. 3, p. 962, doi. 10.3390/biomedicines11030962

By:

Sun, Fangfang;
Wu, Huaxiang;
Wang, Zitao;
Wu, Tong;
Wu, Xue;
Chen, Jie;
Zhang, Danting;
Bao, Chunde;
Shen, Nan;
Wu, Lijun;
Zhu, Jing;
Ye, Shuang

Publication type:

Article

Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS).

Published in:

Journal of Personalized Medicine, 2023, v. 13, n. 4, p. 691, doi. 10.3390/jpm13040691

By:

Zen, Margherita;
Gatto, Mariele;
Depascale, Roberto;
Regola, Francesca;
Fredi, Micaela;
Andreoli, Laura;
Franceschini, Franco;
Urban, Maria Letizia;
Emmi, Giacomo;
Ceccarelli, Fulvia;
Conti, Fabrizio;
Bortoluzzi, Alessandra;
Govoni, Marcello;
Tani, Chiara;
Mosca, Marta;
Ubiali, Tania;
Gerosa, Maria;
Bozzolo, Enrica P.;
Canti, Valentina;
Cardinaletti, Paolo

Publication type:

Article

Combined rituximab and belimumab to treat recalcitrant epidermolysis bullosa aquisita associated with systemic lupus erythematosus.

Published in:

British Journal of Dermatology, 2024, v. 191, n. 1, p. 138, doi. 10.1093/bjd/ljae141

By:

Tull, Thomas J;
Benton, Emma C;
Semkova, Kristina;
Watson, Natalie A;
Mee, John B;
Lopez, Begona;
Setterfield, Jane;
Carey, Barbara;
Ahmad, Sajjad;
Robbie, Scott J;
Groves, Richard W;
Sanna, Giovanni;
D'Cruz, David P

Publication type:

Article

Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study.

Published in:

Frontiers in Immunology, 2023, v. 13, p. 01, doi. 10.3389/fimmu.2022.1074044

By:

Nikoloudaki, Myrto;
Nikolopoulos, Dionysis;
Koutsoviti, Sofia;
Flouri, Irini;
Kapsala, Noemin;
Repa, Argyro;
Katsimbri, Pelagia;
Theotikos, Evangelos;
Pitsigavdaki, Sofia;
Pateromichelaki, Katerina;
Bertsias, Antonios;
Elezoglou, Antonia;
Sidiropoulos, Prodromos;
Fanouriakis, Antonis;
Boumpas, Dimitrios;
Bertsias, George

Publication type:

Article

Effectiveness and safety of Belimumab combined with standard therapy in severe active lupus nephritis requiring kidney replacement therapy: A case report and literature review.

Published in:

Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2022.977377

By:

Chengning Zhang;
Ming Zeng;
Yifei Ge;
Kang Liu;
Changying Xing;
Huijuan Mao

Publication type:

Article

Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.980079

By:

Kirou, Kyriakos A.;
Era, Maria Dall;
Aranow, Cynthia;
Anders, Hans-Joachim

Publication type:

Article

Belimumab in childhood systemic lupus erythematosus: A review of available data.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.940416

By:

Feng Chen;
Ying Zheng;
Xinying Chen;
Zhanfa Wen;
Youjia Xu;
Jinghua Yang;
Kaisi Xu

Publication type:

Article

Editorial: Clinical, Molecular and Adverse Responses to B-Cell Therapies in Autoimmune Disease.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.962088

By:

Sciascia, Savino;
Parodis, Ioannis;
Karim, Mohammed Yousuf

Publication type:

Article

Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects.

Published in:

Journal of Clinical & Aesthetic Dermatology, 2015, v. 8, n. 4, p. 11

By:

WIRTA, DAVID;
BAUMANN, LESLIE;
BRUCE, SUZANNE;
AHLUWALIA, GURPREET;
EMILY WENG;
DANIELS, SELENA

Publication type:

Article

EDITORIAL MESSAGE.

Published in:

Journal of Clinical & Aesthetic Dermatology, 2015, v. 8, n. 4, p. 9

By:

Del Rosso, James Q.;
Werschler, Wm. Philip;
Desai, Seemal R.

Publication type:

Article

New drugs and dosage forms.

Published in:: American Journal of Health-System Pharmacy, 2017, v. 74, n. 17, p. 1296
Publication type:: Article

Effectiveness of Belimumab for Glucocorticoid Discontinuation in Juvenile-Onset Lupus Nephritis.

Published in:

Indian Journal of Nephrology, 2025, v. 35, n. 1, p. 1, doi. 10.25259/IJN_444_2024

By:

Kise, Tomoo;
Uehara, Masatsugu

Publication type:

Article

Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases.

Published in:

2016

By:

Yamada, Hiroshi;
Yoneda, Masahiko;
Gosho, Masahiko;
Kato, Tomohiro;
Zako, Masahiro

Publication type:

journal article

Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial.

Published in:

BMC Ophthalmology, 2015, v. 15, n. 1, p. 1, doi. 10.1186/1471-2415-15-7

By:

Rossetti, Luca;
Sacchi, Matteo;
Karabatsas, Costas H.;
Topouzis, Fotis;
Vetrugno, Michele;
Centofanti, Marco;
Boehm, Andreas;
Vorwerk, Christian;
Goldblum, David;
Fogagnolo, Paolo

Publication type:

Article

Belimumab.

Published in:: Australian Prescriber, 2013, v. 36, n. 4, p. 139
Publication type:: Article

Efficacy and safety of belimumab in the treatment of systemic lupus erythematosus: A meta‑analysis.

Published in:

World Academy of Sciences Journal, 2022, v. 4, n. 2, p. 1, doi. 10.3892/wasj.2022.143

By:

JIACHEN ZHANG;
XIANGYING LIU;
YAN XU;
HONGYAN LI;
YUEXIA XU

Publication type:

Article

Switching efficacy on intraocular pressure from latanoprost to bimatoprost in eyes with open angle glaucoma: implication to the changes of central corneal thickness.

Published in:

Japanese Journal of Ophthalmology, 2014, v. 58, n. 5, p. 423, doi. 10.1007/s10384-014-0336-2

By:

Sawada, Akira;
Yamamoto, Tetsuya

Publication type:

Article

A case of central nervous system nocardiosis in a patient with lupus treated with belimumab.

Published in:

European Journal of Rheumatology, 2016, v. 3, n. 4, p. 188, doi. 10.5152/eurjrheum.2016.15083

By:

Lai, Richard H. C.;
Kim, Deborah;
Constantinescu, Florina

Publication type:

Article

Belimumab for the treatment of pemphigus.

Published in:

Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15621

By:

Ruan, Jiali;
Zhang, Xuetong;
Zheng, Min

Publication type:

Article

Current and emerging treatment options in the management of lupus.

Published in:

ImmunoTargets & Therapy, 2016, v. 5, p. 9, doi. 10.2147/ITT.S40675

By:

Jordan, Natasha;
D'Cruz, David

Publication type:

Article

The beneficial effect of adding belimumab in severe and refractory IgA nephropathy: a case report.

Published in:

Pediatric Nephrology, 2025, v. 40, n. 6, p. 1903, doi. 10.1007/s00467-024-06620-1

By:

Mao, Youying;
Zhang, Chenxing;
Xu, Jing;
Liu, Chong;
Zheng, Song Guo;
Yin, Lei

Publication type:

Article

Do we really need cyclophosphamide for lupus nephritis?

Published in:

Pediatric Nephrology, 2024, v. 39, n. 11, p. 3193, doi. 10.1007/s00467-024-06367-9

By:

Wenderfer, Scott E.;
Cooper, Jennifer C.

Publication type:

Article

Recent advances in immunotherapies for lupus nephritis.

Published in:

Pediatric Nephrology, 2023, v. 38, n. 4, p. 1001, doi. 10.1007/s00467-022-05670-7

By:

Kaneko, Machi;
Jackson, Shaun W.

Publication type:

Article